Latest Stock Split Details
Key information about Lineage Cell Therapeutics, Inc.'s most recent stock split
Split Date: 1997-10-31
Split Ratio: 3:1
Price Before Split: $73.88
Price After Split: $24.63
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 3.00 times more shares (a 3:1 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Lineage Cell Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 1997-10-31 | 3:1 | No | $73.88 | $24.63 |
About Lineage Cell Therapeutics, Inc.
Company overview and industry information
Lineage Cell Therapeutics, Inc. (LCTX) operates in the Biotechnology industry. The recent 3-for-1 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Biotechnology
Go to Lineage Cell Therapeutics, Inc. Summary